This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Response According to Research Diagnostic Criteria Diagnoses and Severity of Illness

Jonathan W. Stewart, MD; Frederic M. Quitkin, MD; Michael R. Liebowitz, MD; Patrick J. McGrath, MD; Wilma M. Harrison, MD; Donald F. Klein, MD

Arch Gen Psychiatry. 1983;40(2):202-207.

Abstract
• The efficacy of desipramine for mild depression was tested in a double-blind, placebo-controlled study of outpatients with scores below 19 on the Hamilton Rating Scale for Depression (HAM-D). Of 103 such patients, 23 dropped out and 16 improved during a ten-day placebo period. Among 64 patients completing the randomized portion of the study, significantly more improved with desipramine than with placebo. The Research Diagnostic Criteria (RDC) category of major depressive disorder largely accounted for the drugplacebo response difference found for the entire sample. Patients with intermittent depressive disorder improved significantly less frequently with desipramine than patients with major depressive disorder. Independent of RDC diagnosis, severity of illness correlated with outcome. Thus, patients with pretreatment HAM-D scores at or above the median demonstrated significant drug effect, while patients with lower pretreatment HAM-D scores did not.

Author Affiliations
From the New York State Psychiatric Institute, New York.

Footnotes
Accepted for publication June 30, 1982.

Reprint requests to New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr Stewart).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines
Anderson et al.
J Psychopharmacol 2008;22:343-396.
ABSTRACT  

Randomized, Placebo-Controlled Trial of Fluoxetine for Acute Treatment of Minor Depressive Disorder
Judd et al.
Am. J. Psychiatry 2004;161:1864-1871.
ABSTRACT | FULL TEXT  

Meta-Analysis of Placebo Rates in Major Depressive Disorder Trials
Stolk et al.
The Annals of Pharmacotherapy 2003;37:1891-1899.
ABSTRACT | FULL TEXT  

Are There Differences Between Women's and Men's Antidepressant Responses?
Quitkin et al.
Am. J. Psychiatry 2002;159:1848-1854.
ABSTRACT | FULL TEXT  

Atypical Depression: A Reappraisal
Parker et al.
Am. J. Psychiatry 2002;159:1470-1479.
ABSTRACT | FULL TEXT  

National Depressive and Manic-Depressive Association Consensus Statement on the Use of Placebo in Clinical Trials of Mood Disorders
Charney et al.
Arch Gen Psychiatry 2002;59:262-270.
ABSTRACT | FULL TEXT  

A Reevaluation of the Exclusion Criteria Used in Antidepressant Efficacy Trials
Posternak et al.
Am. J. Psychiatry 2002;159:191-200.
ABSTRACT | FULL TEXT  

Treatment of Dysthymia and Minor Depression in Primary Care: A Randomized Controlled Trial in Older Adults
Williams et al.
JAMA 2000;284:1519-1526.
ABSTRACT | FULL TEXT  

Medications Versus Cognitive Behavior Therapy for Severely Depressed Outpatients: Mega-Analysis of Four Randomized Comparisons
DeRubeis et al.
Am. J. Psychiatry 1999;156:1007-1013.
ABSTRACT | FULL TEXT  

Primary Care Physicians' Approach to Depressive Disorders: Effects of Physician Specialty and Practice Structure
Williams et al.
Arch Fam Med 1999;8:58-67.
ABSTRACT | FULL TEXT  

National Institute of Mental Health Treatment of Depression Collaborative Research Program: General Effectiveness of Treatments
Elkin et al.
Arch Gen Psychiatry 1989;46:971-982.
ABSTRACT  

Predictors of Drug Response in Depression
Joyce and Paykel
Arch Gen Psychiatry 1989;46:89-99.
ABSTRACT  

Antidepressants: Their efficacy and place in therapy
Paykel
J Psychopharmacol 1988;2:105-118.
ABSTRACT  

The Validity of the Dexamethasone Suppression Test as a Marker for Endogenous Depression
Zimmerman et al.
Arch Gen Psychiatry 1986;43:347-355.
ABSTRACT  

The Validity of Four Definitions of Endogenous Depression: II. Clinical, Demographic, Familial, and Psychosocial Correlates
Zimmerman et al.
Arch Gen Psychiatry 1986;43:234-244.
ABSTRACT  

Treatment Outcome Validation of DSM-III Depressive Subtypes: Clinical Usefulness in Outpatients With Mild to Moderate Depression
Stewart et al.
Arch Gen Psychiatry 1985;42:1148-1153.
ABSTRACT  

Placebo-Control Groups in the Study of Outpatient Depressives
Quitkin and Stewart
Arch Gen Psychiatry 1984;41:1110-1110.
ABSTRACT  

Placebo-Control Groups in the Study of Outpatient Depressives-Reply
Murphy
Arch Gen Psychiatry 1984;41:1110-1111.
ABSTRACT